EIF2AK3 and amyotrophic lateral sclerosis: To reconcile the contradictory results of previous research, we evaluated three commonly used, CNS-penetrant, PERK modulators—GSK2606414, salubrinal, and Sephin1—in the same ALS-relevant screening assay and animal model.